Emerald Advisers, LLC Karuna Therapeutics, Inc. Transaction History

Emerald Advisers, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$161.01 - $317.85 $4.32 Million - $8.52 Million	-26,814 Reduced 97.78%	610 $193,000
Q3 2023 Oct 26, 2023	SELL	$164.66 - $218.08 $38,201 - $50,594	-232 Reduced 0.84%	27,424 $4.64 Million
Q2 2023 Jul 25, 2023	SELL	$176.32 - $240.22 $8.73 Million - $11.9 Million	-49,514 Reduced 64.16%	27,656 $6 Million
Q1 2023 May 04, 2023	SELL	$161.33 - $204.36 $3.83 Million - $4.86 Million	-23,760 Reduced 23.54%	77,170 $14 Million
Q4 2022 Feb 03, 2023	SELL	$191.53 - $236.82 $3.62 Million - $4.48 Million	-18,898 Reduced 15.77%	100,930 $19.8 Million

Q3 2022 Oct 25, 2022	SELL	$123.79 - $277.42 $86,653 - $194,194	-700 Reduced 0.58%	119,828 $27 Million
Q2 2022 Jul 29, 2022	SELL	$93.97 - $143.33 $12.6 Million - $19.2 Million	-134,028 Reduced 52.65%	120,528 $15.2 Million
Q1 2022 Apr 29, 2022	BUY	$98.9 - $132.37 $2.34 Million - $3.14 Million	23,684 Added 10.26%	254,556 $32.3 Million
Q4 2021 Feb 02, 2022	BUY	$110.64 - $159.4 $2.09 Million - $3 Million	18,850 Added 8.89%	230,872 $30.2 Million
Q3 2021 Oct 28, 2021	BUY	$101.2 - $125.87 $769,929 - $957,618	7,608 Added 3.72%	212,022 $25.9 Million
Q2 2021 Jul 29, 2021	BUY	$107.45 - $135.95 $3.36 Million - $4.25 Million	31,290 Added 18.07%	204,414 $23.3 Million
Q1 2021 Apr 29, 2021	BUY	$95.46 - $133.08 $16.5 Million - $23 Million	173,124 New	173,124 $20.8 Million

333K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.